[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Articles archive::
For Reviewers::
Contact us::
Basic and Clinical Biochemistry and Nutrition
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 26, Issue 4 (Bimonthly 2022) ::
Feyz 2022, 26(4): 466-473 Back to browse issues page
Determination of apolipoprotein E genotyping in diabetic patients with cardiovascular diseases with allele specific PCR method
Bahareh Rashidian , Zahra Rezvani
Department of Biotechnology, Faculty of Chemistry, University of Kashan, Kashan, I.R. Iran. , rezvani@kashanu.ac.ir
Abstract:   (877 Views)
Background: Apolipoprotein E (ApoE) is one of the several important lipoproteins in lipid metabolism, and many studies have been conducted on it. In various studies, the role of this protein in diseases such as Alzheimer's disease, cardiovascular disease, diabetes and immune deficiency diseases such as AIDS have been addressed. The gene is a polymorphic apolipoprotein with three transcripts or different alleles called e2, e3 and e4. These three alleles have six genotypes E2E2, E2E3, E2E4, E3E3, E3E4 and E4E4 with different frequency in the population. Depending on the demographic, geographic and racial characteristics of these genotypes, they are seen with varying frequency in the population, which is in any case the highest frequency related to E3E3. In this study determinated apolipoprotein E genotyping in diabetic patients with cardiovascular diseases with allele specific PCR method.
Materials and Methods: This study was performed on 107 blood samples of diabetic patients with cardiovascular disease living in Kashan. To determine the genotype of this gene, allele specific PCR with five primers was used and then the pattern of bands in electrophoresis was used.
Results: The results show that in this population (diabetic patients with cardiovascular disease living in Kashan), as in most Iranian and world populations, the most genotype is E3E3. Also, the frequency of e2, e3 and e4 alleles is 5.1, 79 and 15.9%, respectively.
Conclusion: This study shows that there is an average impact of this genotype on lipoproteins of plasma or types of CVD, so it can be helpful to predict and prevent diseases associated with this genotype.
Keywords: Apolipoprotein E genotype, Cardiovascular disease, Diabetes, Relative allele frequency, Allele specific PCR
Full-Text [PDF 435 kb]   (486 Downloads)    
Type of Study: Research | Subject: General
Received: 2022/04/15 | Revised: 2022/10/19 | Accepted: 2022/09/3 | Published: 2022/09/26
1. available at: https://diabetesatlas.org/ (accessed 27 May 2022)
2. El-Lebedy D, Raslan HM, Mohammed AM. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovasc Diabetol 2016; 15(1): 1.
3. Maratni NP, Saraswati MR, Dewi NN, Yasa IW, Eka Widyadharma IP, Putra IB, Suastika K. Association of Apolipoprotein E Gene Polymorphism with Lipid Profile and Ischemic Stroke Risk in Type 2 Diabetes Mellitus Patients. J Nutr Metab 2021; 2021.
4. Ferreira CN, Carvalho MG, Fernandes AP, Lima LM, Loures-Valle AA, Dantas J, et al. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders. Neurochem Int 2010; 56(1): 177-82.
5. Grundy SM. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 2006; 5(4): 295-309.
6. Kockx M, Traini M, Kritharides L. Cell-specific production, secretion, and function of apolipoprotein E. J Mol Med 2018; 96(5): 361-71.
7. Das H, McPherson J, Bruns G, Karathanasis S, Breslow J. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985; 260(10): 6240-7.
8. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988; 3(4): 373-9.
9. Utermann G, Langenbeck U, Beisiegel U, Weber W. Genetics of the apolipoprotein E-system in man. Am J Hum Genet 1980; 32(3): 339.
10. Mahley RW, Rall Jr SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1(1): 507-37.
11. Martínez‐Magaña JJ, Genis‐Mendoza AD, Tovilla‐Zarate CA, González‐Castro TB, Juárez-Rojop IE, Hernández‐Díaz Y, et al. Association between APOE polymorphisms and lipid profile in Mexican Amerindian population. Mol Genet Genomic Med 2019; 7(11): e958.
12. Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small Ga, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993; 261(5123): 921-3.
13. Schächter F, Faure-Delanef L, Guénot F, Rouger H, Froguel P, Lesueur-Ginot L, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994; 6(1): 29-32.
14. Siest G, Pillot T, Régis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41(8): 1068-86.
15. Marais AD. Apolipoprotein E and atherosclerosis. Curr Atheroscler Rep 2021; 23(7): 1-1.
16. Ceci FM, Ceccanti M, Petrella C, Vitali M, Messina MP, Chaldakov GN, et al. Alcohol drinking, apolipoprotein polymorphisms and the risk of cardiovascular diseases. Curr Neurovasc Res 2021; 18(1): 150-61.
17. Mehta A, Shapiro MD. Apolipoproteins in vascular biology and atherosclerotic disease. Nat Rev Cardiol 2021;1-2.
18. Horejsi B, Ceska R. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein (a) as candidate genes of premature development of atherosclerosis. Physiol Res 2000; 49: S63-S70.
19. Chaudhary R, Likidlilid A, Peerapatdit T, Tresukosol D, Srisuma S, Ratanamaneechat S, et al. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol 2012; 11(1): 36.
20. You H, Chen J, Zhou J, Huang H, Pan J, Wang Z, et al. Amplification refractory mutation system polymerase chain reaction versus optimized polymerase chain reaction restriction-fragment length polymorphism for apolipoprotein E genotyping of majorly depressed patients. Mol Med Rep 2015; 12(5): 6829-34.
21. Yang YG, Kim JY, Park SJ, Kim SW, Jeon OH, Kim DS. Apolipoprotein E genotyping by multiplex tetra-primer amplification refractory mutation system PCR in single reaction tube. J Biotechnol 2007; 131(2): 106-10.
22. Cartier R, Sassolas A. Apolipoprotein E phenotyping by isoelectric focusing in immobilized pH gradients and silver staining. Electrophoresis 1992; 13(1): 252-7.
23. Weisgraber KH, Newhouse YM, Mahley RW. Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide probes. Biochem Biophys Res Commun 1988; 157(3): 1212-7.
24. Zivelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, Seligsohn U. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 1997; 43(9): 1657-9.
25. Tsai M, Suess P, Schwichtenberg K, Eckfeldt J, Yuan J, Tuchman M, et al. Determination of apolipoprotein E genotypes by single-strand conformational polymorphism. Clin Chem 1993; 39(10): 2121-4.
26. Hirtz C, Vialaret J, Nouadje G, Schraen S, Benlian P, Mary S, et al. Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing. Clin Chim Acta 2016; 454: 33-8.
27. Aslanidis C, Schmitz G. High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves. Clin Chem 1999; 45(7): 1094-7.
28. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res1988; 16(3): 1215.
29. Ma W, Ren X, Zhang L, Dong H, Lu X, Feng W. Apolipoprotein E Gene Polymorphism and Coronary Artery Disease Risk Among Patients in Northwest China. Pharmacogenomics Pers Med 2021; 14: 1591.
30. Wang C, Yan W, Wang H, Zhu J, Chen H. APOE polymorphism is associated with blood lipid and serum uric acid metabolism in hypertension or coronary heart disease in a Chinese population. Pharmacogenomics 2019; 20(14): 1021-31.
31. Adler G, Adler MA, Urbańska A, Skonieczna-Żydecka K, Kiseljakovic E, Valjevac A, Parczewski M, Hadzovic-Dzuvo A. Bosnian study of APOE distribution (BOSAD): a comparison with other European populations. Ann Hum Biol 2017; 44(6): 568-73.
32. Afroze D, Yousuf A, Tramboo NA, Shah ZA, Ahmad A. ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population. Clin Experimental Med 2016; 16(4): 551-6.
33. Seo JY, Youn BJ, Cheong HS, Shin HD. Association of APOE genotype with lipid profiles and type 2 diabetes mellitus in a Korean population. Genes Genomics 2021; 43(7): 725-35.
34. Shinohara M, Suzuki K, Bu G, Sato N. Interaction Between APOE Genotype and Diabetes in Longevity. J Alzheimer's Dis 2021; 82(2): 719-26.
35. Koutsodendris N, Nelson MR, Rao A, Huang Y. Apolipoprotein e and alzheimer's disease: Findings, hypotheses, and potential mechanisms. Annu Rev Pathol 2022; 17: 73-99.
36. Palmqvist S, Stomrud E, Cullen N, Janelidze S, Manuilova E, Jethwa A, et al. An accurate fully automated panel of plasma biomarkers for Alzheimer's disease. Alzheimer's Dement 2022 Aug 11.
37. Tao Q, Ang TF, Akhter-Khan SC, Itchapurapu IS, Killiany R, Zhang X, et al. Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous APOE ɛ4 Carriers. Neurology 2021; 97(12): e1243-52.
38. Nichols JB, Malek-Ahmadi M, Tariot PN, Serrano GE, Sue LI, Beach TG. Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease. J Neuropathol Experimental Neurol 2021; 80(3): 240-6.
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rashidian B, Rezvani Z. Determination of apolipoprotein E genotyping in diabetic patients with cardiovascular diseases with allele specific PCR method. Feyz 2022; 26 (4) :466-473
URL: http://feyz.kaums.ac.ir/article-1-4591-en.html

Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 26, Issue 4 (Bimonthly 2022) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4642